Volume 16, Issue 3 (2020) | American Journal of Infectious Diseases

Development of Azithromycin Resistance in Streptococcus pneumoniae in the Setting of Trachoma Mass Drug Administration: A Systematic Review

Nazia Khan — 2020-07-24

American Journal of Infectious Diseases, Published online: 24 July 2020; doi:10.3844/ajidsp.2020.109.117

Trachoma is a blinding eye disease caused by the bacterium Chlamydia trachomatis. The current global elimination of trachoma initiative includes the use of mass drug distribution of azithromycin in ar...

Is Hydroxychloroquine a Safe and Effective Choice for Covid-19 Prophylaxis

Rodrigo Moisés de Almeida-Leite — 2020-07-29

American Journal of Infectious Diseases, Published online: 29 July 2020; doi:10.3844/ajidsp.2020.118.119

The authors speculate about the possibility of Hydroxychloroquine as Covid-19 Phrophylaxis in the dose of 400 mg per week. The authors compared the experience of Malaria phrophylaxis in this dose, wit...

Why Continue Studying HRP2 and HRP3 in Malaria?

María Luz Gunturiz — 2020-08-24

American Journal of Infectious Diseases, Published online: 24 August 2020; doi:10.3844/ajidsp.2020.120.130

The main malaria control strategy is rapid and accurate diagnosis followed by effective treatment. The quality of the diagnosis is relevant, since an erroneous diagnosis can generate an increase in mo...